What Researchers Did
The researchers looked back at the records of 67 patients with sudden hearing loss of unknown cause to compare hearing improvement with and without hyperbaric oxygen added to medicines.
What They Found
In this retrospective study of 67 patients with idiopathic sudden sensorineural hearing loss, patients who received hyperbaric oxygen therapy together with a systemic steroid and prostaglandin E1 showed greater hearing improvement than patients treated without it (p less than 0.01). The two treatment groups differed in some ways. After adjusting for confounding factors, a statistical analysis found a link between pure tone audiometry improvement and hyperbaric oxygen therapy (odds ratio 7.42, 95 percent confidence interval 2.37 to 23.3, p equals 0.001). The abstract as provided does not report the pressure used or the number of sessions.
What This Means for Canadian Patients
For people with sudden hearing loss of unknown cause, this study found that those who also had hyperbaric oxygen therapy alongside a steroid and prostaglandin E1 had greater hearing improvement than those who did not. Because this was a look back at past records and the groups were not the same, it shows an association and does not prove that the oxygen therapy caused the improvement. Anyone considering treatment should talk with their own physician.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study was retrospective, and the abstract notes some differences between the two treatment groups, so the results may reflect those differences and not the treatment alone.